ADAP-话题@MedSci

#ADAP#

8篇内容 | 299人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1779030, encodeId=95031e790301b, content=<a href='/topic/show?id=5e05194410' target=_blank style='color:#2F92EE;'>#ADAP#</a>, objectTitle=武田收购Adaptate Biotherapeutics，以开发针对实体瘤的新型Gamma Delta (γδ) T细胞衔接器疗法, objectType=article, longId=294032, objectId=36af294032f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36af294032f6, replyNumber=0, likeNumber=37, createdTime=2022-03-12, rootId=0, userName=kalseyzl, userId=c77e138, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36af294032f6, moduleTitle=武田收购Adaptate Biotherapeutics，以开发针对实体瘤的新型Gamma Delta (γδ) T细胞衔接器疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36af294032f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779028, encodeId=aea71e7902871, content=<a href='/topic/show?id=5e05194410' target=_blank style='color:#2F92EE;'>#ADAP#</a>, objectTitle=浅谈基于效果反应的适应性随机化 (Response-Adaptive Randomization), objectType=article, longId=183035, objectId=4b911830358a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4b911830358a, replyNumber=0, likeNumber=33, createdTime=2020-02-24, rootId=0, userName=kalseyzl, userId=c77e138, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4b911830358a, moduleTitle=浅谈基于效果反应的适应性随机化 (Response-Adaptive Randomization), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4b911830358a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779029, encodeId=ba011e790291d, content=<a href='/topic/show?id=5e05194410' target=_blank style='color:#2F92EE;'>#ADAP#</a>, objectTitle=安进联合Adaptive：开发针对新冠病毒的中和性抗体, objectType=article, longId=191369, objectId=eacd1913697a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eacd1913697a, replyNumber=0, likeNumber=60, createdTime=2020-10-19, rootId=0, userName=kalseyzl, userId=c77e138, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eacd1913697a, moduleTitle=安进联合Adaptive：开发针对新冠病毒的中和性抗体, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eacd1913697a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779027, encodeId=896f1e790270e, content=<a href='/topic/show?id=5e05194410' target=_blank style='color:#2F92EE;'>#ADAP#</a>, objectTitle=Adaptimmune和Noile-Immune宣布合作，开发增强型SPEAR T细胞肿瘤免疫疗法, objectType=article, longId=178294, objectId=d7c31e8294c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d7c31e8294c4, replyNumber=0, likeNumber=33, createdTime=2019-10-04, rootId=0, userName=kalseyzl, userId=c77e138, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d7c31e8294c4, moduleTitle=Adaptimmune和Noile-Immune宣布合作，开发增强型SPEAR T细胞肿瘤免疫疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d7c31e8294c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779026, encodeId=d6021e79026e3, content=<a href='/topic/show?id=5e05194410' target=_blank style='color:#2F92EE;'>#ADAP#</a>, objectTitle=Am J Cardiol: ADAPT-DES研究：高血压合并氯吡格雷抵抗患者远期事件风险高, objectType=article, longId=178280, objectId=73931e828030, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73931e828030, replyNumber=0, likeNumber=30, createdTime=2020-08-01, rootId=0, userName=kalseyzl, userId=c77e138, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73931e828030, moduleTitle=Am J Cardiol: ADAPT-DES研究：高血压合并氯吡格雷抵抗患者远期事件风险高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73931e828030)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779025, encodeId=21801e7902506, content=<a href='/topic/show?id=5e05194410' target=_blank style='color:#2F92EE;'>#ADAP#</a>, objectTitle=J Endod：Twisted File Adaptive和Navigator EVO器械在不同运动模式下根管偏移、定心能力以及循环疲劳比较, objectType=article, longId=147077, objectId=d1c714e077dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1c714e077dc, replyNumber=0, likeNumber=30, createdTime=2018-08-31, rootId=0, userName=kalseyzl, userId=c77e138, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1c714e077dc, moduleTitle=J Endod：Twisted File Adaptive和Navigator EVO器械在不同运动模式下根管偏移、定心能力以及循环疲劳比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d1c714e077dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779024, encodeId=8e6a1e79024b1, content=<a href='/topic/show?id=5e05194410' target=_blank style='color:#2F92EE;'>#ADAP#</a>, objectTitle=Blood：ADAP缺陷可影响巨核细胞极化、促进血小板前体异位释放，从而导致微血小板减少症, objectType=article, longId=142211, objectId=ce0814221166, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce0814221166, replyNumber=0, likeNumber=22, createdTime=2019-04-25, rootId=0, userName=kalseyzl, userId=c77e138, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce0814221166, moduleTitle=Blood：ADAP缺陷可影响巨核细胞极化、促进血小板前体异位释放，从而导致微血小板减少症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce0814221166)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779023, encodeId=13ff1e79023a5, content=<a href='/topic/show?id=5e05194410' target=_blank style='color:#2F92EE;'>#ADAP#</a>, objectTitle=免疫测序界重磅新闻：Adaptive收购Sequenta，一跃成为行业巨头, objectType=article, longId=45399, objectId=22784539980, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=22784539980, replyNumber=0, likeNumber=35, createdTime=2015-04-04, rootId=0, userName=kalseyzl, userId=c77e138, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=22784539980, moduleTitle=免疫测序界重磅新闻：Adaptive收购Sequenta，一跃成为行业巨头, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=22784539980)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ADAP

2020-05-29

kalseyzl (审核中...)

前往app查看评论内容

#ADAP#

武田收购Adaptate Biotherapeutics，以开发针对实体瘤的新型Gamma Delta (γδ) T细胞衔接器疗法

2022-03-12

kalseyzl (审核中...)

前往app查看评论内容

#ADAP#

浅谈基于效果反应的适应性随机化 (Response-Adaptive Randomization)

2020-02-24

kalseyzl (审核中...)

前往app查看评论内容

#ADAP#

安进联合Adaptive：开发针对新冠病毒的中和性抗体

2020-10-19

kalseyzl (审核中...)

前往app查看评论内容

#ADAP#

Adaptimmune和Noile-Immune宣布合作，开发增强型SPEAR T细胞肿瘤免疫疗法

2019-10-04

kalseyzl (审核中...)

前往app查看评论内容

#ADAP#

Am J Cardiol: ADAPT-DES研究：高血压合并氯吡格雷抵抗患者远期事件风险高

2020-08-01

kalseyzl (审核中...)

前往app查看评论内容

#ADAP#

J Endod：Twisted File Adaptive和Navigator EVO器械在不同运动模式下根管偏移、定心能力以及循环疲劳比较

2018-08-31

kalseyzl (审核中...)

前往app查看评论内容

#ADAP#

Blood：ADAP缺陷可影响巨核细胞极化、促进血小板前体异位释放，从而导致微血小板减少症

2019-04-25

kalseyzl (审核中...)

前往app查看评论内容

#ADAP#

免疫测序界重磅新闻：Adaptive收购Sequenta，一跃成为行业巨头

2015-04-04

科室
- - 订阅+
  - 更多科室
工具
服务